SMMART Program: A multi-omics tumour board with a focus on breast cancer
SMMART Program: A multi-omics tumour board with a focus on breast cancer
PC14586: The first orally bioavailable small molecule reactivator of Y220C mutant p53 in clinical development
Adjuvant therapy with nivolumab combined with ipilimumab vs nivolumab alone in patients with resected stage IIIB-D/IV melanoma
Highlights from AORTIC Cancer Genomics Conference 2021
ecancer special issue on medical education in Africa
UICC Breast Cancer Programme: update and opportunities
OncoAlert and ecancer weekly roundup for February 01 - 06, 2021
Latest in EGFR-positive NSCLC with exon 20 insertion mutations
WCLC 2020 overview
OncoAlert and ecancer weekly roundup for January 25 - 31, 2021
Highlights from BGICC 2021
OncoAlert and ecancer weekly roundup for January 18 - 24, 2021